There is no significant association between death receptor 4 (dr4) gene polymorphisms and lung cancer in Turkish population

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 779-784

  Taştemir Korkmaz, Deniz ^a   Demirhan, Osman ^b   Kuleci, Sedat ^b   Hastürk, Serap ^c  

^a ADIYAMAN UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

^c Acibadem Hospital   (Turkey)

Author keywords

Death receptor 4; Lung cancer; Polymorphisms

Indexed keywords

DEATH RECEPTOR 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH RECEPTOR 4 GENE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TURKEY;

EID: 84885181415     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9643-z     Document Type: Article

References (15)

1. Dechant MJ, Fellenberg J, Scheuerpflug CG, Ewerbeck V, Debatin K-M (2004) Mutation Analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines. Int J Cancer 109:661-667
2. Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X (2003) Death receptor 4 and bladder cancer risk. Cancer Res 63:1157-1159
3. Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS (2001) Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7:1688-1697
4. Martinez-Ferrandis JI, Rodriguez-Lopez R, Milne RL, Gonzalez E, Cebolla E, Chirivella I, Zamora P, Arias JI, Palacios S, Cervantes A, Diez O, Benitez J, Armengod ME (2007) Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark 3(2):89-93
5. Horak P, Pils D, Roessler M, Tomek S, Elandt K, Zeillinger R, Zielinski C, Krainer M (2005) Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer. Gynecol Oncol 97:514-518
6. Seitz S, Wassmuth P, Fischer J, Nothnagel A, Jandrig B, Schlag PM, Scherneck S (2002) Mutation analysis and mRNA expression of trail-receptors in human breast cancer. Int J Cancer 102:117-128
7. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Kang CS, Kim KM, Jang JJ, Nam SW, Lee JY, Yoo NJ (2001) Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 20(3):399-403
8. Ulybina YM, Kuligina ES, Mitiushkina NV, Rozanov ME, Ivantsov AO, Ponomariova DN, Togo AV, Levchenko EV, Shutkin VA, Brenister SI, Devilee P, Zhivotovsky B, Hirvonen A, Imyanitov EN (2009) Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett 278(2):183-191
9. Wang M, Wang M, Cheng G, Zhang Z, Fu G, Zhang Z (2009) Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer. Mutat Res 661:85-92
10. Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B (2006) Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 15(10):2002-2005
11. Lu G, Bing X, Qi S, Chun L (2007) Association of DR4 gene polymorphism in Chinese patients with gastroduodenal diseases. Med J Wuhan Univ 28:93-95
12. Wolf S, Mertens D, Pscherer A, Schroeter P, Winkler D, Gröne HJ, Hofele C, Hemminki K, Kumar R, Steineck G, Döhner H, Stilgenbauer S, Lichter P (2006) Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lumphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. Int J Cancer 118:1831-1835
13. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4:563-571
14. Chen B, Liu S, Wang X-L, Xu W, Li Y, Zhao W-H, Wu (2009) TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur J Cancer 45:2598-2605
15. Fernandez V, Jares P, Bea S, Salaverria I, Guino E, de Sanjose S, Colomer D, Ott G, Montserrat E, Campo E (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica 89:1322-1331